HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Bhargava, J. S. Articles by King, A. J. Search for Related Content PubMed PubMed Citation Articles by Bhargava, J. S. Articles by King, A. J.

Views of Glaucoma Patients on Aspects of Their Treatment: An Assessment of Patient Preference by Conjoint Analysis

¹From the Department of Ophthalmology, Queen’s Medical Centre, Nottingham, United Kingdom; and the ²Division of Primary Care, University of Nottingham, Nottingham, United Kingdom.

PURPOSE. To determine by conjoint analysis which factors in the management and treatment of glaucoma were of most importance to patients and to relate these factors to the patient’s clinical glaucoma condition.

METHODS. An interview-based study was performed. Demographic and visual function data are recorded. Participants completed the Visual Function Questionnaire-25 and ranked 10 hypothetical patient scenarios that contained different risks of moderate visual loss, postoperative complications, long-term blindness, use of topical medication, and glaucoma surgery. Conjoint analysis was performed to determine the relative importance of these factors for individuals and the group as a whole.

RESULTS. Eighty-two patients were interviewed from two consultants’ outpatient clinics. Forty-five were male and 37 female. Seventy-nine were white. The most important factors to patients with glaucoma were the risk of moderate visual impairment and the risk of blindness, with an importance of 38% and 27%, respectively. The use of topical medication had an importance of 11%. Proceeding to surgical intervention (trabeculectomy) had an importance of 15%, and the small risk of visual deterioration after surgery (trabeculectomy) had an importance of 9%.

CONCLUSIONS. To patients, the most important factors regarding glaucoma and its treatment are the risks of moderate visual loss (the ability to continue to drive) and long-term blindness. The treatment methods used are of much less importance.

This article has been cited by other articles:

				N. K. Janz, D. C. Musch, B. W. Gillespie, P. A. Wren, L. M. Niziol, and for the Collaborative Initial Glaucoma Treatment S Evaluating Clinical Change and Visual Function Concerns in Drivers and Nondrivers with Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1718 - 1725. [Abstract] [Full Text] [PDF]

				J S Bhargava, A Bhan-Bhargava, A J E Foss, and A J King Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis Br. J. Ophthalmol., December 1, 2008; 92(12): 1601 - 1605. [Abstract] [Full Text] [PDF]

				V. M. F. Owen, D. P. Crabb, E. T. White, A. C. Viswanathan, D. F. Garway-Heath, and R. A. Hitchings Glaucoma and Fitness to Drive: Using Binocular Visual Fields to Predict a Milestone to Blindness Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2449 - 2455. [Abstract] [Full Text] [PDF]

				P. A. Aspinall, Z. K. Johnson, A. Azuara-Blanco, A. Montarzino, R. Brice, and A. Vickers Evaluation of Quality of Life and Priorities of Patients with Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1907 - 1915. [Abstract] [Full Text] [PDF]